*By Carlo Versano*
The world's largest beverage maker is reportedly eyeing the red-hot cannabis market, according to a [report] (https://www.bnnbloomberg.ca/coca-cola-in-talks-with-aurora-to-develop-cannabis-drinks-sources-1.1138528).
Coca-Cola is in "serious talks" with Aurora Cannabis to develop cannabidiol-infused beverages, according to BNN Bloomberg.
A deal on that scale would likely dwarf agreements made by Corona-maker Constellation Brands and Molson Coors, both of which have partnered with Canadian cannabis companies to add CBD, the non-psychoactive ingredient in cannabis that can be used to treat pain or anxiety, to drinks like coffee, soda, and beer, and would represent a "mainstreaming" of pot products in the eyes of Wall Street.
For Coke, getting into the weed market would be both capturing a trend and a diversification play. Soda sales have been down as younger consumers seek out healthier drinks like sparkling water.
Shares of Aurora were up over 6 percent on the news Monday morning, as were other pot stocks like Tilray.
President Donald Trump has signed the GENIUS Act into law, setting new regulations for stablecoins, a type of cryptocurrency tied to assets like the U.S. dollar.
The switch from high-fructose corn syrup in Coke sold in the United States would put Coca-Cola in line with its practice in other countries, including Mexico.
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
